Alcohol (ethanol) produces activating and depressing behavioral effects in humans. We have investigated the basis for an activating effect of ethanol in C. elegans that produces body hypercontraction. Acute ethanol exposure induces a shortening of the animal that requires normal acetylcholine levels and a functional UNC-63 acetylcholine receptor (AChR) subunit. Elimination of the two receptors currently known to contain the UNC-63 subunit, the ACR-2R and the levamisole-sensitive AChR, do not alter sensitivity to ethanol. This suggests that UNC-63 may be acting in an unidentified receptor to mediate this effect of ethanol. AChRs in mammals have been implicated in mediating activating effects of ethanol, and genetic variation in AChR subunit-encoding genes has been associated with the development of alcoholism in humans. We are pursuing the tissue-specific requirements for
unc-63 expression for its role in this ethanol effect.The hypercontracted animals show a recovery of pre-treatment body length despite continuous exposure to ethanol (and a gradual increase in internal ethanol concentration). This observation suggests that a physiological tolerance is developing to the drug. We identified the
eat-6(
eg200) mutation as a mutant that fails to develop tolerance to this ethanol effect. An examination of several existing alleles of
eat-6 found that mutants with strong effects on pharyngeal pumping did not alter the response to ethanol-induced hypercontraction, whereas the
ad601 allele, which resembles the
eg200 mutant in having weak effects on pumping but strong effects on aldicarb sensitivity, does alter the maintenance of tolerance to ethanol. These data suggest that
eg200 and
ad601 alter a specific function of the Na+/K+-ATPase that is important for the development and/or maintenance of tolerance to ethanol for this cholinergic activating effect of ethanol. One possibility that we are testing, is that EAT-6 has a structural relationship with an ethanol-sensitive AChR, and that the mutations
eg200 and
ad601 prevent desensitization or compensatory trafficking of that receptor.